Neurological Research and Practice (Jan 2021)

Off-label intravenous thrombolysis for early recurrent brain embolism associated with aortic arch thrombus

  • Ioanna Koutroulou,
  • Georgios Tsivgoulis,
  • Vasileios Rafailidis,
  • Elissavet Psoma,
  • Konstantinos Kouskouras,
  • Panagiotis Fotiadis,
  • Nikolaos Grigoriadis,
  • Theodoros Karapanayiotides

DOI
https://doi.org/10.1186/s42466-021-00103-6
Journal volume & issue
Vol. 3, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Safety data of intravenous thrombolysis (IVT) in presence of aortic arch thrombus is scant. Furthermore, IVT is debatable in patients with prior recent stroke. We present a 51-year-old woman with recurrent major infarction 5 days after a minor left MCA territory stroke. She had a floating aortic arch thrombus and she was treated safely and effectively with off-label IVT. Patients with small infarct volumes and mild/no residual neurological deficits after an initial stroke might be considered for IVT in case of early recurrence. IVT may be reasonable in a context of acute severely disabling stroke associated with aortic arch thrombus.

Keywords